Moore Capital Management, LP Liquidia Corp Transaction History
Moore Capital Management, LP
- $5.25 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding LQDA
# of Institutions
157Shares Held
35.9MCall Options Held
1.79MPut Options Held
380K-
Patient Square Capital LP Menlo Park, CA7.18MShares$70.4 Million40.01% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$41.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$33.3 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.4MShares$23.5 Million13.89% of portfolio
-
State Street Corp Boston, MA2.23MShares$21.9 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $631M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...